BCHE and Alzheimer disease: A recent meta-analysis of 10 AD drug RCTs showed that the AD Assessment Scale–Cognitive Subscale (ADAS-Cog) scores decreased (indicating improvement) in the cholinesterase inhibitor treatment group but increased (indicating worsening cognition) in the control group.